Skip to content
Search

Latest Stories

Modi Predicts India's Economy Will be $5 Trillion In 'Near Future'

INDIA'S economy will double in size to $5,000 billion ($5 trillion) in the near future, prime minister Narendra Modi said.

The country was a "land of opportunities" to investors, the prime minister told a business summit in Seoul, during his visit to the Republic of Korea today (21).


"No other large economy in the world is growing at over seven per cent year after year," Modi added.

More than 600 South Korean companies - including Hyundai, Samsung and LG Electronics – have invested in India and the visiting prime minister said, "We aspire to welcome many more."

Car maker Kia is set to join this club, he added.

To ease business visits, India has provided South Korean nationals visa on arrival since October 2018, the prime minister said.

India is among the top 10 trade partners of South Korea and India is the sixth largest export destination for Korean goods.

Trade between the two nations reached $21.5 bn in 2018.

"Our vision of a India-Korea Startup Centre will provide a hub for Korean startups and Indian talent to freely communicate.

“South Korea’s national IT promotion agency has already opened Indian offices in Bengaluru," Modi said.

(PTI)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less